Zapnometinib treatment and influenza A virus infection modulate the HLA class I ligandome in human lung adenocarcinoma cells - Top-Institutions - MDSpire

Zapnometinib treatment and influenza A virus infection modulate the HLA class I ligandome in human lung adenocarcinoma cells

  • By

  • Hazem Hamza

  • Michael Ghosh

  • Hans-Georg Rammensee

  • Oliver Planz

  • May 26, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    University of Virginia School of Medicine
    University of Virginia School of Medicine

    Charlottesville, Virginia

    Key Differentiators

    • Oncology

  • #2

    UVA’s Beirne B. Carter Center for Immunology Research
    UVA’s Beirne B. Carter Center for Immunology Research

    Charlottesville, Virginia

    Key Differentiators

    • Immunology
    • Oncology

  • #3

    UVA’s Division of Infectious Diseases and International Health
    UVA’s Division of Infectious Diseases and International Health

    Charlottesville, Virginia

    Key Differentiators

    • Infectious Diseases
    • Oncology

  • #4

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #5

    Roswell Park Comprehensive Cancer Center
    Roswell Park Comprehensive Cancer Center

    Buffalo, New York

    Key Differentiators

    • Oncology

Original Source(s)

Zapnometinib treatment and influenza A virus infection modulate the HLA class I ligandome in human lung adenocarcinoma cells

  • by Hazem Hamza, Michael Ghosh, Hans-Georg Rammensee, Oliver Planz

  • May 26, 2026

Related Content

Editorial: Overcoming resistance to immune checkpoint inhibitors: mechanisms and strategies in cancer therapy

CT-Based Assessment of Malignancy Risk in Part-Solid Pulmonary Nodules Utilizing Vascular Distortion and Interruption Analysis

Association of high-density lipoprotein cholesterol with the top 10 causes of death